These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Photolyases: capturing the light to battle skin cancer.
    Author: Garinis GA, Jans J, van der Horst GT.
    Journal: Future Oncol; 2006 Apr; 2(2):191-9. PubMed ID: 16563088.
    Abstract:
    Photolyases comprise efficient enzymes to remove the major UV-induced DNA lesions, cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs). While photolyases are present in all three kingdoms of life (i.e., bacteria, prokaryotes and eukaryotes), placental mammals appear to have lost these enzymes when they diverted from marsupials during evolution. Consequently, man and mice have to rely solely on the more complex and, for these lesions, less efficient nucleotide excision repair (NER) system. To assess the relative contribution of CPDs and 6-4PPs to the cytotoxic and genotoxic effects of the UV component of sunlight, we have recently generated a comprehensive set of transgenic mice expressing CPD and/or 6-4PP photolyases. Here, we discuss the use of photolyase transgenic mice as effective tools to study the adverse effects of UV irradiation.
    [Abstract] [Full Text] [Related] [New Search]